Skip to content

Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma

Effects of Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03260231
Acronym
Lymphoseed
Enrollment
40
Registered
2017-08-24
Start date
2017-05-12
Completion date
2021-12-31
Last updated
2020-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-hodgkin Lymphoma

Brief summary

Recent literature data suggest beneficial effects of dietary fats in patients with cancers, in particular polyunsaturated fatty acids (PUFAs). Milled mix of flax, sesame and pumpkin seeds provides a high amount of PUFAs and a desirable n-6/n-3 PUFAs ratio.

Detailed description

Cancers are characterized by inflammation and alternations in lipid and fatty acid metabolism. Patients with non-Hodgkin lymphoma have impaired fatty acid profiles, low level of PUFAs, and high n-6/n-3 PUFAs ratio. Moreover, these changes are related to clinical outcome. Flax seeds, sesame and pumpkin seeds are rich sources of PUFAs. Dietary intake of milled mix of these seeds has been shown to decrease inflammation and improve PUFAs status in patients on hemodialysis and to decrease breast cancer risk. The study design is single-blind, controlled, randomized nutritional intervention. The participants are randomly assigned into intervention and control group before starting chemotherapy. All patients receive nutritional counseling to achieve a daily energy and protein intake according to recommended dietary allowances, with (intervention) or without (control) of milled seed mix.

Interventions

DIETARY_SUPPLEMENTMilled seed mix

Dietary intervention with or without seed mix

Sponsors

University of Belgrade
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Investigator)

Masking description

Single blind

Intervention model description

This study is a parallel, randomized, single blind, controlled, 5-months nutritional intervention, investigating health effects of dietary intake of milled mix of flax/sesame pumpkin seeds in sour milk, in patients with NHL undergoing chemotherapy. At the beginning of the study, all patients received nutritional counselling, where half of the study subjects are randomly assigned to a treatment arm with milled seed mix consumption, or control arm without seed mix. Treatment arm is provided with 450g of milled seed mix and instructed to consume 30g of the mix daily (18g flax seed, 6g pumpkin seeds, and 6 g sesame) in 180 mL of sour milk. Control arm is instructed to consume180 mL of sour milk.

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Histologically confirmed Non-Hodgkin lymphoma * Patients able to understand requirements of the study and provide written informed consent

Exclusion criteria

* Previous radio- or chemotherapy * Other serious chronic diseases * Statin therapy * Presence of allergy on any seeds * Use of fat-based dietary supplements (such as fish oil, evening primrose oil etc) 3 months prior to study

Design outcomes

Primary

MeasureTime frameDescription
Change in disease statusBaseline, 5 months, 1 yearRemission, stable disease or progression
Change in quality of life questionnaire scoresBaseline, 5 months, 1 yearAssessed by standardized questionnaires

Secondary

MeasureTime frameDescription
Changes in lipid profilesBaseline, 5 months, 1 yearChanges in lipid profiles (cholesterol, HDL, LDL and triglycerides) from baseline to endpoint
Changes in plasma fatty acidsBaseline, 5 months, 1 yearChanges in plasma fatty acids profiles from baseline to endpoint
Changes in body weightBaseline, 5 months, 1 yearChanges in body weight measured by bio-impedance analyzer, from baseline to endpoint
Changes in interleukin (IL)-6Baseline, 5 months, 1 yearChanges in interleukin (IL)-6 from baseline to endpoint
Changes in parameters of oxidative stressBaseline, 5 monthsMeasures of activities of the following enzymes: SOD, catalase, glutathion peroxidase and glutation reductase
Changes in CRPBaseline, 5 months, 1 yearChanges in CRP from baseline to endpoint
Changes in leukocyte countBaseline, 5 months, 1 yearMeasures of leukocyte count

Countries

Serbia

Contacts

Primary ContactZorica Cvetkovic, MD PhD
zokabora@yahoo.com+381641302624
Backup ContactSnjezana Petrovic, PhD
+381113031997

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026